Mission Bio raises $30M in Series B round to develop genomics platform
The company said it would use the funding to expand its single-cell DNA sequencing platform into CRISPR applications and global markets.
Cota Capital
The company said it would use the funding to expand its single-cell DNA sequencing platform into CRISPR applications and global markets.